To include your compound in the COVID-19 Resource Center, submit it here.

HspE7: Phase II

Additional data from a Phase II trial in 27 patients showed that the first post-treatment interval increased

Read the full 179 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE